Rafoxben

COMPOSITION
Rafoxben Oral Suspension is a light yellow-yellow colored oral suspension containing 100 mg fenbendazole and 100 mg rafoxanide per ml. It also contains 0.50 mg sodium metabisulfite (E 223) as an antioxidant and preservative, 1.00 mg methyl parahydroxybenzoate and 0.10 mg propyl parahydroxybenzoate as antimicrobial preservatives, and 0.09 mg quinoline yellow (E 104) as a coloring agent per ml.

INDICATIONS FOR USE
Rafoxben Oral Suspension permits a three-way activity against Parasite, Lungworms and Stomach worms in Cattle. It is a broad spectrum anthelmintic for the treatment of benzimidazole susceptible mature and immature stages of nematodes and cestodes of the gastrointestinal and respiratory tracts of cattle.
Rafoxanide is active against immature and mature Fasciola sp. (over 8 weeks of age.)
Cattle:
Haemonchus sp., Ostertagia sp., Trichostrongylus sp., Cooperia sp., Nematodirus sp., Bunostomum sp., Trichuris sp., Strongyloides sp., Oesophagostomum sp., Dictyocaulus sp., Moniezia sp., Fasciola hepatica (mature or immature and over 8 weeks of age)
RAFOXBEN Oral Suspension has a good therapeutic effect against type II Ostertagiasis.

OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES)
RAFOXBEN Oral Suspension is well tolerated in cattle at three times the recommended dosage.
Loss of appetite, diarrhea, ataxia, mydriasis, retinal necrosis and detachment, and permanent blindness may occur. There is no known antidote for fenbendazole and rafoxanide. Supportive and symptomatic treatment is applied. In addition to activated charcoal administration after oral poisoning, gastric lavage is recommended.
 
WITHDRAWAL PERIOD(S)
Cattle should not be slaughtered for human consumption during treatment or for 60 days thereafter. Do not use during the last trimester of pregnancy in cows which are intended to produce milk for human consumption